EN DE

Perfect Medical Health Management Limited (PFSMF) Fair Value & Analysis

Healthcare · US · Market cap $302M

PM Perfect Medical Health Management Limited logo Perfect Medical Health Management Limited PFSMF · US
Price$0.2401
Fair Value$0.3800
Upside+58.3%
Quality82/100
Watch Perfect Medical Health Management Limited for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Solidly profitable · 16.2% net margin
generates free cash flow
Ranks above peers (8/9)
Wide moat 76/100
Evidence: High Range $0.2900 – $0.5200 Share as image

Fair value as of: Jul 21, 2026

From 22 valuation models · updated 20 days ago

A strong business, screening 58% undervalued on our models.

What matters now

  • The rarer combination: high quality (82/100) AND below fair value. That earns a closer look rather than a quick verdict.
  • The price is below even our cautious bear case ($0.2900). The market is more pessimistic than our downside scenario.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (3 years)

$0.3945 $0.1950 Fair Value $0.3800 May 2023 Jul 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.

How to read this chart

39‑month range $0.1950 – $0.3945 · fair‑value band $0.2900 – $0.5200 · the $0.2401 price screens below the $0.3800 fair value. Dashed = 300-day average. As of Jul 21, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Perfect Medical Health Management Limited (PFSMF) currently trades at $0.2401, while our model-based Fair Value estimate is $0.3800, implying the stock looks roughly 58.3% undervalued today. The Quality Score stands at 82/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Perfect Medical Health Management Limited generated revenue of $993M at a net margin of 16.2%. Revenue declined 21.7% year over year. It earns a return on equity of 38.3%. The stock trades on a trailing P/E of 12.0. Fundamentals as of Jul 21, 2026

Our scenario range runs from $0.2900 (bear case) to $0.5200 (bull case); at $0.2401, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 8% below its 52-week high and 23% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 58%, PFSMF screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $2.19 $2.74 $3.60 72
Growth-Adj P/E $1.75 $2.50 $3.25 68
Rev-Margin DCF $1.85 $2.55 $3.42 67
All 22 models by family
DCF Models
FCF DCF $2.12 $2.71 $3.69 38
Owner Earnings $2.46 $3.15 $4.30 31
5Y Revenue Exit $1.85 $2.50 $3.44 39
5Y EBITDA Exit $2.65 $3.87 $5.49 41
5Y P/E Exit $2.23 $3.16 $4.26 38
10Y Revenue Exit $1.93 $2.39 $2.87 36
10Y EBITDA Exit $2.40 $3.16 $3.97 37
10Y P/E Exit $2.17 $2.76 $3.31 35
Earnings-Based
Graham-Dodd $1.12 $1.37 $1.54 54
EPV $1.46 $1.63 $1.78 59
Multiples
P/E Multiple $2.47 $3.29 $4.12 63
P/S Multiple $1.68 $2.24 $2.81 58
P/B Multiple $0.6800 $0.9000 $1.13 55
EV/EBIT $2.89 $3.79 $4.69 53
EV/EBITDA $3.53 $4.64 $5.75 54
EV/Revenue $1.77 $2.44 $3.12 43
Asset-Based
NCAV (Graham) $0.1500 $0.2000 $0.3000 50
Growth DCF
Growth DCF $2.19 $2.74 $3.60 72
Rev-Margin DCF $1.85 $2.55 $3.42 67
Economic Profit
Residual Income $1.21 $2.00 $33.42 61
ROIC Compounder $1.46 $1.64 $1.80 67
Growth Earnings
Growth-Adj P/E $1.75 $2.50 $3.25 68

Widest divergence: DCF Models ($2.76) versus Asset-Based ($0.2000). Highest evidence: Growth DCF (72).

Notify me when PFSMF reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $993M
Revenue growth (YoY) -21.7%
Net margin 16.2%
Return on equity 38.3%
Free cash flow $298M FY2025
P/E ratio 12.0
More key figures
Operating margin 22.5%
EPS (TTM) $0.0200
EPS growth (YoY) -33.0%

Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 82/100

Of which business quality 82 · Market factors (momentum, volatility) 50

Profitability 94
Margins and returns on capital today
Quality Growth 32
Are margins and returns improving?
Cashflow 91
Earnings quality: real cash, not paper profit
Fin. Strength 85
Balance sheet, leverage, solvency risk
Investment 98
Disciplined investing over empire-building
Low Volatility 70
Calm price path (market factor)
Momentum 38
Price trend over the last 3–12 months (market factor)
52W Momentum 48
Distance to the 52-week high (market factor)
Net Issuance 80
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Perfect Medical Health Management Limited, an investment holding company, engages in the provision of medical, aesthetic medical, and beauty and wellness services in Hong Kong, the People's Republic of China, Macau, Australia, and Singapore.

Full company description

Perfect Medical Health Management Limited, an investment holding company, engages in the provision of medical, aesthetic medical, and beauty and wellness services in Hong Kong, the People's Republic of China, Macau, Australia, and Singapore. The company offers pain management and hair growth treatments; preventive care and fertility care services; and sleep therapy treatment services under the Goku Spa brand name. It also provides advertising, charitable, and management services, as well as holds trademarks and rents equipment. The company was formerly known as Perfect Shape Medical Limited and changed its name to Perfect Medical Health Management Limited in June 2021. Perfect Medical Health Management Limited was founded in 2003 and is headquartered in Mong Kok, Hong Kong.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Perfect Medical Health Management Limited reported revenue of $1.1B in FY2025 versus $1.1B in FY2021, a compound +0.9%/yr. Reported net income was $207M in FY2025, compounding −7.7%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$1.1B
Latest YoY
−19.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−5.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.9%
Revenue +0.9%/yr
FY21 $1.1B
FY22 $1.3B
FY23 $1.4B
FY24 $1.4B
FY25 $1.1B
Net income −7.7%/yr
FY21 $285M
FY22 $305M
FY23 $316M
FY24 $316M
FY25 $207M

Watch PFSMF: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Perfect Medical Health Management Limited Fair Value". https://www.fairvalue-calculator.com/stock/PFSMF

Peer Group

Medical Care Facilities · 261 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 82 · Top 25%
Fair Value upside +58% · Top 25%
Return on equity (TTM) 38% · Top 25%
Return on assets 13% · Top 25%
Net margin (TTM) 16% · Top 25%
Operating margin (TTM) 22% · Top 25%
Revenue growth -22% · Bottom 25%

Valuation Multiples vs Medical Care Facilities median · lower = cheaper

P/E (TTM) 12.0× · Cheaper than 75% of peers
P/FCF 1.0× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 23
FUTURE 0 · sector 24
PAST 100 · sector 30
HEALTH 0 · sector 90
DIVIDEND 0 · sector 38

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).

Stock Price Fair Value vs Fair Value
HCA Healthcare, Inc HCA $378.85 $554.93 +46%
Fresenius SE FRE €41.73 €32.15 -23%
Dr. Sulaiman Al Habib Medical Services Group 4013 235.00 SAR 112.37 SAR -52%
IHH Healthcare Berhad, an investment holding company, Q0F 2.58 SGD 1.44 SGD -44%
Tenet Healthcare Corporation THC $194.91 $338.05 +73%
Rede D'Or São Luiz S.A RDOR3 R$36.01 R$47.31 +31%
DaVita Inc DVA $231.61 $255.97 +11%
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,955 ₹2,955 -67%
Fresenius Medical Care AG FMS $24.68 $45.60 +85%
Aier Eye Hospital Group 300015 ¥8.68 ¥7.67 -12%

Compare Perfect Medical Health Management Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Perfect Medical Health Management Limited (PFSMF) overvalued or undervalued?
As of Jul 21, 2026, our model estimates a fair value of $0.3800 versus a price of $0.2401, about +58% (undervalued).
What is the fair value of PFSMF?
Our model-based fair value for Perfect Medical Health Management Limited is $0.3800 (as of Jul 21, 2026), built from audited fundamentals. The current price is $0.2401.
What is the quality score of PFSMF?
Perfect Medical Health Management Limited has a Quality Score of 82/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Perfect Medical Health Management Limited (PFSMF)?
Perfect Medical Health Management Limited reported trailing-twelve-month revenue of about $993M (latest available figure, as of Jul 21, 2026).
What is the net profit margin of PFSMF?
The net profit margin of Perfect Medical Health Management Limited is about 16.2%, meaning it keeps roughly 16.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Perfect Medical Health Management Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.